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Abstract
Background
Bacterial cell quantification after exposure to antimicrobial compounds varies widely
throughout industry and healthcare. Numerous methods are employed to quantify these
antimicrobial effects. With increasing demand for new preventative methods for disease
control, we aimed to compare and assess common analytical methods used to determine
antimicrobial effects of novel nanoparticle combinations on two different pathogens.
Methods
Plate counts of total viable cells, flow cytometry (LIVE/DEAD BacLight viability assay)
and qPCR (viability qPCR) were used to assess the antimicrobial activity of engineered
nanoparticle combinations (NPCs) on Gram-positive (Staphylococcus aureus) and Gram-
negative (Pseudomonas aeruginosa) bacteria at different concentrations (0.05, 0.10 and
0.25 w/v%). Results were analysed using linear models to assess the effectiveness of differ-
ent treatments.
Results
Strong antimicrobial effects of the three NPCs (AMNP0–2) on both pathogens could be
quantified using the plate count method and flow cytometry. The plate count method showed
a high log reduction (>8-log) for bacteria exposed to high NPC concentrations. We found
similar antimicrobial results using the flow cytometry live/dead assay. Viability qPCR analy-
sis of antimicrobial activity could not be quantified due to interference of NPCs with qPCR
amplification.
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Conclusion
Flow cytometry was determined to be the best method to measure antimicrobial activity of
the novel NPCs due to high-throughput, rapid and quantifiable results.
Introduction
Antimicrobial compounds, solutions and procedures are widely used in the biopharmaceutical
and healthcare industry for disinfection and decontamination of pathogens from processes,
equipment and devices. Therefore, it is important to use quantitative methods that provide an
accurate assessment of how effective these antimicrobial strategies are at decontamination.
Within the biologics manufacturing industry, it is common to use viral or bacterial products
as raw starting materials when developing a new product or device. However, after develop-
ment, the manufacturer must be able to demonstrate that their processes can remove any con-
tamination and that the products or devices are safe for human use [1]. The ability to assess
decontamination processes is also important in healthcare settings, such as hospitals, to help
control and prevent the spread of infectious disease. With the increase in multidrug-resistant
infections and ineffective antibiotics, preventative methods for disease control within hospitals
are in increasing demand. Currently, hospitals employ a wide variety of disinfection and
decontamination procedures, which include filtration devices, use of solvents/detergents and
heat treatments [2]
Numerous analytical methods are currently being used within these industries to help
quantify the antimicrobial effects of these current disinfection compounds and procedures.
However, comparison between different methods and results is often difficult due to non-stan-
dardised procedures, the variety of available methods and variation in experimental design [3].
Effectively assessing antimicrobial activity is a hotly debated topic with several methods
being used. Currently, one of the most common methods used within hospitals and industry
to measure antimicrobial activity is the plate count method for microbial enumeration [4,5].
The plate count method involves serially diluting a culture of bacteria to count colony forming
units (CFU) on an agar plate. This method is cheap, easy to use and requires minimal training
to perform. However, it is time consuming and labour intensive. Furthermore, issues arise
when viable but non-culturable (VBNC) cells are present. VBNC cells have intact membranes
and genomic material but their metabolic functions might differ from viable, culturable cells
and they can no longer grow on standard media [6]. Many cells might enter this state when
under stress, such as exposure to an antimicrobial compound or other sub-optimal abiotic
conditions. VBNC can pose risks to public health if there has been an underestimation of total
viable, pathogenic bacterial cells.
The use of fluorescent dyes (propidium iodide, SYTO19 and propidium monoazide) are
used throughout different techniques as a rapid way to distinguish between populations and
determining the viability of cells [7,8], but results can often be variable and cannot be used to
determine species of bacteria. One method that uses these fluorescent markers is flow cytome-
try. A common assay is the LIVE/DEAD BacLight viability assay which uses propidium iodide
to stain cells with damaged membranes and SYTO19 which can penetrate damaged and intact
membranes [8]. This assay can give a quick, comprehensive and quantifiable overview of the
bacterial population. However, flow cytometry requires a large, initial investment and exten-
sive training to competently calibrate the instrumentation, set up complex assays and analyse
data but methods can be validated to be in line with ISO standards.
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Other methods to determine antimicrobial activity which are now more commonly used,
such as molecular methods, do not require the culturing of bacteria. Quantitative polymerase
chain reaction (qPCR) is now being used to assess the effectiveness of antimicrobial com-
pounds and procedures due to decreasing cost and the ability to generate rapid results. qPCR
can detect and quantify the amount of target genomic material present within a sample thus
eliminating the requirement to culture cells. To differentiate between live and dead cells, a via-
bility PCR assay can be used [9]. This involves incubating samples with a DNA-binding dye,
such as propidium monoazide (PMA) which binds to free DNA (including dead cells with
damaged membranes) which interferes with the PCR amplification by inhibition and therefore
live cells are only detected and amplified during PCR [10].
Metallic nanoparticles have been used as antimicrobials for centuries [11]. Researchers are
keen to develop new, effective antimicrobial compounds and procedures that reduce cost and
the requirement for multiple disinfectants and procedures to prevent contamination. It is now
widely known that metallic nanoparticles show strong antimicrobial effects whilst remaining
non-toxic to human cells [12–15] with silver being used in several applications such as drug
delivery, wound repair and catheters [16]. With nanoparticle integration into medical devices
and equipment on the rise, NPCs offer a promising solution to help develop broad-spectrum
antimicrobial devices to these multi drug-resistant pathogens in both biopharmaceutical and
healthcare industries, eliminating the requirement for other, more laborious methods of
decontamination.
For this study a combination of metallic nanoparticles (tungsten carbide (WC), silver
(AgNP) and copper (CuNP)) were selected to create nanoparticle combinations (NPCs). We
chose these NPs due to the strong evidence for AgNP and CuNPs to produce a strong antimi-
crobial effect against several species of bacteria [12–15]. There is some limited evidence that
WC nanoparticles produce an antimicrobial effect [14]. Gram-positive (S. aureus) and Gram-
negative (P. aeruginosa) bacterial cells were then exposed to the NPCs at different concentra-
tions (0.05, 0.10 and 0.25 w/v %). S. aureus and P. aeruginosa are common hospital pathogens
that can cause serious illness in immune compromised patients. Many strains of S. aureus are
known to be resistant to multiple antibiotics and the organism is a known contaminant of sur-
gical equipment and medical devices [17,18]. P. aeruginosa readily forms biofilms and can be
fatal to patients that have suffered from traumatic burns or ventilator associate pneumonia
(VAP) [19].
Here we have tested our novel NPCs and assessed their antimicrobial activity by performing
a comparison of proven current antimicrobial assays. The effectiveness of these combinations
was analysed by three different methods: plate count, flow cytometry (live/dead assay) and
qPCR (viability PCR assay). The performance of these approaches was assessed through a
series of microbiological and analytical techniques.
Materials and methods
Nanoparticle preparation
All nano powders including AMNP0, AMNP1 and AMNP2, WC, Ag and Cu were engineered
by Qinetiq Nanomaterials1 using patented Tesima™ thermal plasma technology (Farnbor-
ough, UK) [20]. The chemical contents of formulations AMNP 0, 1 and 2 were previously
reported and found to contain different ratios of W, C, Ag and Cu. In particular, particle sizes
of AMNP 1 and 2 were found to be in a range of 10–20 nm [21].
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Growth of bacterial strains
Bacteria stock cultures of P. aeruginosa (NCTC 12903) and S. aureus (ATTC 6538P) were
obtained from -80˚C freezer stocks containing 30% glycerol. Each stock solution was streaked
onto Tryptic Soya Agar (TSA) using a sterile loop and incubated at 37˚C for 24 hours. After
incubation, a single colony of each strain was grown in Luria broth (LB) and placed on a
shaker (150 rpm) for a further 24 hours at 37˚C. A 1:100 dilution of the overnight culture of
each pathogen and inoculated into NPC preparations at three concentrations 0.25, 0.10 and
0.05 w/v %, in triplicate with LB broth and incubated at 37˚C, shaken (150 rpm) for 24 hours.
In each of the experiments we included a positive control with no treatment, a positive control
of bacteria exposed to 200μg/ml antibiotic Oxytetracycline, and bacteria-free controls of each
treatment and negative controls with no treatment of bacterial cells added.
Plate count
Viable bacterial cell concentrations were estimated by counting CFU’s before and after expo-
sure to the NPCs. This was performed by serial dilution in LB and then removing 10μl of the
serially diluted culture and spreading with sterile glass beads (5mm, Sigma, UK) onto an agar
plate (Tryptic Soya Agar) in triplicate. The plates were then incubated at 37˚C for 24 hours
and CFUs were counted. Results for log reduction is shown in Fig 1.
Flow cytometry
To determine bacterial viability after exposure to nanoparticles by flow cytometry, The LIVE/
DEAD BacLight Bacterial viability assay (ThermoFisher, UK) was used. A stock solution of
propidium iodide and SYTO19 was prepared according to manufacturer’s instructions. 180μl
of the stock staining solution was added to 20μl of diluted sample, in triplicate with appropri-
ate controls, to 1.5ml microcentrifuge tubes and incubated at room temperature in the dark
for 15 minutes.
Using a calibrated Guava easyCyte1 flow cytometer (Merck, UK), the sample was acquired
using InCyte software (Merck, UK) and 50,000 events were collected. The bacteria acquisition
gate was determined according to forward scatter (FSC) and side scatter (SSC) channels to
eliminate background noise and debris. The live and dead populations of bacteria were distin-
guished by fluorescent channels FL1 (live populations SYTO19) vs FL3 (dead populations PI),
as shown in Fig 2. Populations of live and/or dead bacteria were gated according to fluores-
cence minus one (FMO) controls using single stains of SYTO9 and PI.
PMA treatment
To determine live and dead populations after exposure to nanoparticle combinations by
qPCR, propidium monoazide (Biotium, Inc) was dissolved in 20% DMSO (Sigma, UK) in a
light- permeable microcentrifuge tube to a concentration of 20nM. Samples were centrifuged
and re-suspended in 500 μl sterile distilled water. 20nM of PMA was added to the re-sus-
pended sample in a transparent microcentrifuge tube and incubated for 5 minutes in the dark.
After incubation, samples were placed on ice and exposed to 650W halogen light source for 2
minutes with mixing at a 20cm distance [22].
DNA extraction
All DNA extractions were performed using QIAamp DNA Mini Kit (Qiagen, UK) extraction
kit according to manufacturer’s instructions.
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qPCR
qPCR procedures were performed on Applied Biosystems 7500 Real-time PCR system
(Applied Biosystems, UK). All primers and probes for P. aeruginosa and S. aureus were based
on published literature [23,24] listed in Table 1 and synthesised by Sigma Aldrich, UK. DNA
was amplified in 25μl reaction volumes containing 0.1μM of each primer and probe. Amplifi-
cation and detection was determined using TaqMan Universal PCR Master Mix (x2) (Thermo,
UK).
Briefly, the amplification profile was as follows: 50˚C for 2 min, 95˚C for 10 min, 40 cycles
at 95˚C for 15 sec and 40 cycles 60˚C for 1 min.
Statistical analysis
All data are expressed as means ± standard deviation (SD). Statistical analyses were performed
using R Studio (v 1.0.136, USA) software, with graphics coded via ggplot2 package. Data was
checked for normality (Shapiro-Wilk test). Statistical analyses of data were performed using
Students paired t-test or one-way ANOVA with post hoc Tukeys and a significant difference is
defined as P< 0.05.
Fig 1. Bar graph showing log reduction for a) P. aeruginosaand b) S. aureus for three AMNP nanoparticle composites (AMNP0, 1 and 2) at
different NPC concentrations (0.05, 0.10 and 0.25 w/v%) with an antibody control (Ab control). A log reduction of>8-log shows complete
inhibition of bacterial growth. Data is expressed as mean (n = 3)-/+ SD.
https://doi.org/10.1371/journal.pone.0192093.g001
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Results
To investigate how effective each assay was at determining the antimicrobial effect of the NPCs,
three methods were utilised: plate count, flow cytometry (live/dead) and qPCR (viability).
Plate count
Colonies of P. aeruginosa and S. aureus were counted after 24 hours incubation with NPCs at
different concentrations (0.05, 0.10 and 0.25 w/v %). Complete inhibition of bacteria at 0.25 w/
Fig 2. Gating strategy used to determine ‘live’ populations of bacteria after exposure to NPCs (stained positive for
SYTO9) and ‘dead’ populations of bacteria (stained positive for propidium iodide). Bacterial populations were
gated using positive and negative controls alongside FMO controls. (Gated using FlowJo V10, TreeStar).
https://doi.org/10.1371/journal.pone.0192093.g002
Table 1. Primers and probes for sequence amplification and detection (qPCR).
Primer Target Sequence Reference
Probe S. aureus 5’ FAM – TAG GCG CAT TAG CAG TTG CAT A – BHQ1 5’
Primer (F) S. aureus 5’ – GTA GAT TGG GCA ATT ACA TTT TGA AGG – 3’ Cloutman-green., (2015)24
Primer (R) S. aureus 5’ – CGC ATC TGC TTT GTT ATC CCA TGT A – 3’
Probe P. aeruginosa 50 FAM – AGG TAA ATC CGG GGT TTC AAG GCC – TAMRA 30
Primer (F) P. aeruginosa 50 – TCC AAG TTT AAG GTG GTA GGC TG-30 Schwartz et al., (2006)23
Primer (R) P. aeruginosa 50- CTT TTC TTG GAA GCA TGG CAT C-30
https://doi.org/10.1371/journal.pone.0192093.t001
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v% concentration was observed for both P. aeruginosa and S. aureus for AMNP1 and 2
(>8-log reduction). At 0.10 w/v % there was also complete inhibition of growth when exposed
to AMNP2 for P. aeruginosa and AMNP1 for S. aureus. 0.05 w/v% had a reduction of growth
but complete inhibition was not observed for either P. aeruginosa or S. aureus (~3-log reduc-
tion). AMNP0 was not shown to have an effect on growth of either pathogen at all concentra-
tions (<0.5-log) with similar results to the control (no treatment, <0.2 log reduction). Fig 1
shows log reduction values after NPC treatment.
A one-way ANOVA shows a significant difference overall between NPC treatments
(AMNP0–2) for P. aeruginosa and S. aureus, respectively (Fig 1a: F3,26 = 20.84, P = 0.001 and b:
F3,26 = 21.75, P = 0.001). Post hoc Tukeys HSD test showed a significant difference between
AMNP0 and all other treatments (P< 0.001) with the exception of the control (P = 0.99),
which was not significant when compared with AMNP0 or AMNP1 with AMNP2 (P = 0.99)
for both P. aeruginosa and S. aureus.
Flow cytometry
Populations of bacteria acquired by flow cytometry were analysed using FlowJo V10 (TreeStar,
USA), gating strategy is shown in Fig 2. Proportions of live and dead bacteria within one popu-
lation exposed to the NPC treatments were used to indicate the overall viability of the bacterial
population before and after exposure (Fig 3). Dark purple bars show ‘live’ populations of bacte-
ria, whilst light purple bars indicate ‘dead’ populations.
A one-way ANOVA was used to analyse differences between treatments and concentra-
tions. A significant difference was shown between all treatments for proportion of live (F2,6 =
2284, P = 0.001) and dead bacteria (F2,6 = 41.58, P = 0.001) for P. aeruginosa and S. aureus,
respectively. Significant differences were shown between AMNP0 and all other treatments
(AMNP1 and 2), (P< 0.001 for live and dead bacteria for P. aeruginosa and S. aureus). No sig-
nificant difference was shown between treatments AMNP1 and 2 for both live and dead bacte-
ria (P> 0.7). Overall, for all concentrations there is an increasing trend of ‘dead’ bacteria as
NPC concentration increased for AMNP1 and 2.
qPCR
To distinguish live and dead populations using qPCR, viability qPCR assay was performed
with the addition of propidium monoazide (PMA). PMA blocks amplification of free DNA,
i.e. dead cells. ΔCT was calculated by subtracting the mean post-treatment CT values from the
mean control CT values. ΔCT values above 0 show an increase in amplification (i.e. more cells
with more DNA). ΔCT values below 0 show a decrease in amplification (i.e. fewer cells and
less DNA).
Fig 4 shows a trend for ΔCT values above 0 in the absence of PMA (qPCR-only) when com-
pared with samples treated with PMA for both S. aureus and P. aeruginosa (qPCR-PMA).
Typically, positive ΔCT values were also shown for P. aeruginosa and S. aureus at lowest
concentration of NPC exposure (0.05 w/v%). Negative ΔCT values were observed when patho-
gens were exposed to higher concentrations of NPCs (0.10 and 0.25 w/v%) suggesting a higher
rate of dead cells within the population.
To determine the effect of PMA treatment, a paired t-test was performed. Results show a
significant difference for S. aureus (t26 = 6.59, P = 0.001) and P. aeruginosa (t26 = 9.49, P =
0.001) when comparing qPCR-PMA and qPCR-only.
Furthermore, a one way ANOVA showed a significant difference between NPC treatments
(AMNP0–2) for P. aeruginosa qPCR-PMA (F2,24 = 61.98, P = 0.001) and no significant differ-
ence with qPCR-only (F2,24 = 0.144, P = 0.86). There were also significant differences between
Methods to assess antibacterial activity of nano combinations
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NPCs (AMNP0–2) for S. aureus for both qPCR-PMA (F2,24 = 30.01, P = 0.001) and qPCR-only
(F2,24 = 11.2, P = 0.001).
P. aeruginosa shows a prominent distinction of ΔCT values between qPCR-PMA and
qPCR-only. Positive ΔCT values occur when P. aeruginosa with qPCR-only and negative ΔCT
values are observed when P. aeruginosa is exposed to PMA (qPCR-PMA). However, this is not
as clear with Gram-positive, S. aureus which also show negative ΔCT values with (qPCR-PMA)
and without (qPCR-only) the addition of PMA.
Discussion
Methods used for quantifying antimicrobial activity vary in industry and in healthcare. Cur-
rently, plate counts, flow cytometry and qPCR are all common methods for assessing antimi-
crobial activity, however, there is little consistency between assays in industry and the
healthcare profession. The plate count method on solid media has been used for several
decades [25] and is still common practice. However, with the decreasing cost of more quantita-
tive assays, namely molecular methods, plate count has fallen out of favour as being time con-
suming and laborious.
Here, various methods of determining the antimicrobial activity of different NPCs at vari-
ous concentrations (0.05, 0.10 and 0.25 w/v %) were tested. The data indicate that overall, a
strong comparable antimicrobial effect could be determined using the plate count method (Fig
1), flow cytometry (Fig 3) and qPCR-PMA method (Fig 4).
The plate count method gave a semi-quantitative assessment of antimicrobial activity of the
NPCs by giving an estimate of the overall concentration of live bacteria cells before and after
Fig 3. Mean (n = 3) flow cytometry data for proportion of live and dead bacterial populations after exposure to NPCs (AMNP0, 1, 2 and
antibiotic control (oxytetracycline)) with a) P. aeruginosaand b) S. aureus. Proportions of live and dead were calculated using the total absolute cell
count by the Guava easyCyte flow cytometer which was determined through gating of the live and dead cell populations (FlowJo V10, TreeStar).
https://doi.org/10.1371/journal.pone.0192093.g003
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exposure. However, by using flow cytometry, we were able to quantify the proportions of live
and dead cells within a bacterial population using LIVE/DEAD BacLight Viability kit (Ther-
moFisher, UK), which enabled a much more quantitative measurement of cell viability before
and after exposure to NPC treatments when compared to plate count estimates. Although flow
cytometry is more accurate and quantitative, we see a similar trend in reduction of live bacteria
with increasing concentrations of NPCs for both pathogens (with the exception of AMNP0)
when comparing flow cytometry with the plate count method.
From qPCR-PMA, results show a similar trend to flow cytometry and plate count as nega-
tive ΔCT values (i.e. dead cells) occur when S. aureus and P. aeruginosa have been exposed to
higher concentrations of NPCs for both AMNP1 and AMNP2. However, plate count and flow
cytometry show a clear distinction between AMNP1 and 2 with AMNP0, which shows no anti-
microbial activity. With qPCR-PMA, AMNP0 results suggest there might be some antimicro-
bial activity occurring at higher concentrations, in particular P. aeruginosa with negative ΔCT
values. It is thought that nanoparticles might interfere with the qPCR amplification as they are
also known to bind to DNA [26]. PMA also works by binding to free DNA within the sample,
including cells that have a damaged membrane [22]. This binding of both the NPCs and PMA
might have led to results that show inconsistent data and interference with qPCR amplifica-
tion. This was also demonstrated in a study by Wang et al., (2005) where silicon NPs were
proven to interfere with the qPCR amplification [27].
A distinction between positive and negative ΔCT values was observed for P. aeruginosa
with qPCR-PMA treated cells (Fig 4), however, this was not as prominent for S. aureus. It is
thought that this could be due to differences in cell wall structure and ability of the bacteria to
uptake charged particles. As P. aeruginosa cells have wide, non-specific porin channels, this
Fig 4. Comparison to determine the effectiveness of qPCR-PMA and qPCR only to distinguish between live and dead cells. P. aeruginosa (a) and S.
aureus (b) were exposed to different concentrations of NPCs (0.05, 0.10 and 0.25 w/v %) for 24 hours and an Ab control. qPCR-only and qPCR-PMA
was used to detect cell lysis via measurement of ΔCT. ΔCT values below 0 show a decrease in amplification (less DNA, dead cells) and ΔCT values above
0 show an increase in amplification (more DNA, live cells). Data expressed as mean (n = 3) -/+ SD.
https://doi.org/10.1371/journal.pone.0192093.g004
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could allow the PMA to penetrate the Gram-negative cells more readily than Gram-positive
bacterial cells [28]. Moreover, Gram-negative bacteria like P. aeruginosa, lack teichoic acids
and the peptidoglycan cell wall is much thinner in comparison to Gram-positive bacteria such
as S. aureus. S. aureus has a much thicker cell wall, made up of several layers of peptidoglycan
(up to 100nm thick) with teichoic acids embedded within these layers [29]. This tough exterior
of the Gram-positive S. aureus might have blocked PMA from penetrating the cells as effec-
tively and therefore no clear distinction could be made between qPCR-PMA and qPCR-only
treatments.
Combinations AMNP1–2 showed strong antimicrobial activity for both S. aureus and P.
aeruginosa. Consistently higher inhibition of growth of the Gram-negative organism was
shown in comparison to S. aureus for both plate count and flow cytometry. This could be due
to the composition of the bacterial cell wall and ability to resist antimicrobial compounds. It is
the increased cell wall strength that is thought to give Gram-positive bacteria a higher level of
protection against antimicrobial agents such as certain antibiotics [30].
AMNP0 was constituted of 100% tungsten carbide NPs and demonstrated no antimicrobial
activity for plate count method or flow cytometry. qPCR-PMA showed mostly positive (or
close to 0) ΔCT values when compared to other combinations, indicating the majority of cells
to be live, with (qPCR-PMA) and without (qPCR-only) PMA treatment. A study by Syed et al.,
(2010)[14] showed bacteriostatic activity for tungsten nanoparticles against S. aureus, thought
to be attributed to generation of reactive oxygen species (ROS), however, here, with tungsten
carbide, we saw no evidence for antimicrobial activity. This could be due to the size of the
nanoparticles that were used in this study, which were larger (10-20nm), compared to Syed
et al., who used NPs <10nm. Having smaller nanoparticles increases the surface area in which
they can disrupt the cell membrane of the pathogen leading to cell destruction [31].
Overall, it is thought that toxicity of the nanoparticles to microorganisms occurs when the
nanoparticles disrupt the cell membrane causing free radical formation and reactive oxygen
species (ROS) to develop [15], however, this differs between bacterial species and nanoparti-
cles. Some studies suggest silver and copper nanoparticles affect the primary cell wall structure
of Gram-positive bacteria (e.g. Staphylococcus aureus), in particular the glycan strands and
peptide branches [32,33]. However, the mechanisms of this remain unclear. There is limited
evidence that tungsten nanoparticles might have some antibacterial effect with one study
showing an inhibition of S. aureus and E. coli growth after exposure to these nanoparticles
[14].
Silver and copper nanoparticles are thought to effect Gram-negative bacteria (such as P.
aeruginosa) by interrupting transcription factors, thus preventing quorum sensing signals that
cause biofilm formation and pathogenicity[34,35]. Silver is also known to have potent effects
on organisms such as E. coli, Pseudomonas spp. and the protozoan pathogen Cryptosporidium
[12,36,37]. When comparing S. aureus, flow cytometry and plate count methods, the plate
count method showed higher rate antimicrobial activity with high log reductions for AMNP1
and 2. However, the same exposure showed lower antimicrobial activity for the same nanopar-
ticle compositions (AMNP1 and 2) when analysed by flow cytometry with a higher proportion
of live cells than suggested by the plate count method. As flow cytometry is not affected by via-
ble but non culturable cells, we suggest this could be a reason as to why a slightly higher anti-
microbial activity with S. aureus exposed to AMNP1 and 2 was seen using the plate count
method. In contrast to this, the qPCR method for S. aureus with (qPCR-PMA) and without
PMA (qPCR-only) showed negative ΔCT values in comparison when exposed to high concen-
trations of NPCs which was also shown for AMNP0 qPCR-PMA and qPCR-only, suggesting
more live cells were amplified. However, unlike the plate count method and flow cytometry,
Methods to assess antibacterial activity of nano combinations
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with qPCR-PMA no distinction could be made as to which NP composite (AMNP0–2) was
the best antimicrobial using qPCR only.
Interference from NPCs was not shown with either the plate count method or flow cytome-
try. Flow cytometry did not show NPC interference throughout the assay when comparing
bacteria-free controls containing no NPCs and bacteria-free NPC controls. NPCs remained
undetectable in the fluorescence channels.
In summary, this comparison of three commonly used methods to determine antimicrobial
activity showed best results were achieved using flow cytometry. This high-throughput method
showed no interference by NPCs and allowed distinction between live and dead populations of
cells. The plate count method also remained unaffected by the NPCs, however, this method
was time consuming due to large volume of samples and less accurate due to the inability to
detect viable but non-culturable cells. Similar results were found in a study by Pan et al.,
(2014) who determined flow cytometry to be most accurate when comparing with plate count
methods and spectrophotometry [38]. qPCR data was not as quantifiable as plate count or flow
cytometry with no clear distinction between live and dead cells when comparing qPCR-only
and qPCR-PMA between NPCs at all concentrations. Therefore, it was determined that this
was the least accurate method for determining antimicrobial activity of nanoparticles.
The data presented here gives an overall assessment of common methods used in industry
and in the healthcare profession for determining antibacterial activity of procedures and pro-
cesses with use of nanoparticles which could be useful in the food, pharmaceutical and cos-
metic industries.
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